Karim Iskander

33 papers and 802 indexed citations i.

About

Karim Iskander is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Karim Iskander has authored 33 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 25 papers in Hematology and 15 papers in Oncology. Recurrent topics in Karim Iskander’s work include Multiple Myeloma Research and Treatments (24 papers), Protein Degradation and Inhibitors (14 papers) and Cancer Treatment and Pharmacology (7 papers). Karim Iskander is often cited by papers focused on Multiple Myeloma Research and Treatments (24 papers), Protein Degradation and Inhibitors (14 papers) and Cancer Treatment and Pharmacology (7 papers). Karim Iskander collaborates with scholars based in United States, France and Germany. Karim Iskander's co-authors include Anil K. Jaiswal, Ola Landgren, Roberto Barrios, Amos Gaikwad, Cory Brayton, Marilène Paquet, Delwin J. Long, Hermann Einsele, Robert Z. Orlowski and Hossein Borghaei and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Co-authorship network of co-authors of Karim Iskander i

Fields of papers citing papers by Karim Iskander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karim Iskander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karim Iskander. The network helps show where Karim Iskander may publish in the future.

Countries citing papers authored by Karim Iskander

Since Specialization
Citations

This map shows the geographic impact of Karim Iskander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karim Iskander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karim Iskander more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2025